12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Deals

Opko, Prolor deal

Opko will acquire Prolor Biotech in a stock deal that the companies said values Prolor at about $480 million. Under the deal, Prolor shareholders will receive 0.9951 Opko shares for every Prolor share held. The deal, which has been approved by the boards of both...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >